Literature DB >> 16461799

B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus.

Sergey Yurasov1, Johanna Hammersen, Thomas Tiller, Makoto Tsuiji, Hedda Wardemann.   

Abstract

Antibodies are protective effector molecules in the body's immune defense against pathogens. However, if directed against the body's own tissues or organs, antibodies can also play a role in the pathogenesis of autoimmune disease. Here, we discuss our data on how autoreactive antibodies are regulated in healthy humans and how a failure to establish self-tolerance during early B-cell development in patients with systemic lupus erythematosus may predispose to the development of this autoimmune disease.

Entities:  

Mesh:

Year:  2005        PMID: 16461799     DOI: 10.1196/annals.1358.019

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

Review 1.  Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.

Authors:  A Vossenkämper; P M K Lutalo; J Spencer
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 2.  BAFF and selection of autoreactive B cells.

Authors:  Zheng Liu; Anne Davidson
Journal:  Trends Immunol       Date:  2011-07-13       Impact factor: 16.687

3.  Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.

Authors:  Christian Schmidt; Dongkyoon Kim; Gregory C Ippolito; Hassan R Naqvi; Loren Probst; Shawn Mathur; German Rosas-Acosta; Van G Wilson; Athenia L Oldham; Martin Poenie; Carol F Webb; Philip W Tucker
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

4.  A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.

Authors:  Thomas Tiller; Ingrid Schuster; Dorothée Deppe; Katja Siegers; Ralf Strohner; Tanja Herrmann; Marion Berenguer; Dominique Poujol; Jennifer Stehle; Yvonne Stark; Martin Heßling; Daniela Daubert; Karin Felderer; Stefan Kaden; Johanna Kölln; Markus Enzelberger; Stefanie Urlinger
Journal:  MAbs       Date:  2013-04-09       Impact factor: 5.857

5.  Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry.

Authors:  Susan Malkiel; Venkatesh Jeganathan; Stacey Wolfson; Nataly Manjarrez Orduño; Emiliano Marasco; Cynthia Aranow; Meggan Mackay; Peter K Gregersen; Betty Diamond
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

6.  Multiparameter flow cytometry and bioanalytics for B cell profiling in systemic lupus erythematosus.

Authors:  Denise A Kaminski; Chungwen Wei; Alexander F Rosenberg; F Eun-Hung Lee; Ignacio Sanz
Journal:  Methods Mol Biol       Date:  2012

7.  Expansion of polyreactive B cells cross-reactive to HLA and self in the blood of a patient with kidney graft rejection.

Authors:  F Porcheray; J DeVito; Y Helou; I Dargon; J W Fraser; P Nobecourt; J Ferdman; S Germana; T C Girouard; T Kawai; S L Saidman; W Wong; R B Colvin; C Leguern; E Zorn
Journal:  Am J Transplant       Date:  2012-04-17       Impact factor: 8.086

8.  Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Authors:  Agnès Doreau; Alexandre Belot; Jérémy Bastid; Benjamin Riche; Marie-Claude Trescol-Biemont; Bruno Ranchin; Nicole Fabien; Pierre Cochat; Claire Pouteil-Noble; Pierre Trolliet; Isabelle Durieu; Jacques Tebib; Berhouz Kassai; Stéphane Ansieau; Alain Puisieux; Jean-François Eliaou; Nathalie Bonnefoy-Bérard
Journal:  Nat Immunol       Date:  2009-05-31       Impact factor: 25.606

Review 9.  The BLyS family: toward a molecular understanding of B cell homeostasis.

Authors:  John F Treml; Yi Hao; Jason E Stadanlick; Michael P Cancro
Journal:  Cell Biochem Biophys       Date:  2008-11-26       Impact factor: 2.194

10.  Carboxypeptidase D: a novel TGF-beta target gene dysregulated in patients with lupus erythematosus.

Authors:  Norman-Philipp Hoff; Daniel Degrandi; Ulrich Hengge; Klaus Pfeffer; Jens Ulrich Wurthner
Journal:  J Clin Immunol       Date:  2007-07-20       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.